Electroacupuncture combined with HDAC1 inhibitor suppress tumor growth via improving the recruitment of intratumor CD8+ T cells for triple-negative breast cancer in mice
Triple-negative breast cancer (TNBC) is known for its aggressive nature and poor prognosis, primarily due to limited treatment options stemming from immune evasion mechanisms. This study aimed to explore the therapeutic potential of peritumoral electroacupuncture (EA) in inhibiting tumor growth in T...
Saved in:
| Main Authors: | Yehong Tian, Yinjie Ma, Xue Li, Gang Lu, Shixin Wang, Xiaowei Qiu, Xu Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1584722/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01) -
Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study
by: Beate Vajen, et al.
Published: (2025-05-01) -
Mechanisms of HDACs in cancer development
by: Ying Zhang, et al.
Published: (2025-04-01) -
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
by: Christine Tran, et al.
Published: (2025-02-01) -
Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy
by: Chandrashekar Mataguru Doreswamy, et al.
Published: (2025-05-01)